MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01724pam a2200349 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
5509 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
BD-DhEWU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20180208110455.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
980116s1998 nyua g b 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0824798848 (alk. paper) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)38270589 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| -- |
BD-DhEWU |
| Language of cataloging |
eng |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS189 |
| Item number |
.A37 1998 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1901 |
| Edition number |
22 |
| Item number |
AHI 1998 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Ahuja, Satinder, |
| 9 (RLIN) |
8806 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Impurities evaluation of pharmaceuticals / |
| Statement of responsibility, etc |
Satinder Ahuja. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
Marcel Dekker, |
| Date of publication, distribution, etc |
1998. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
iv, 293 p. : |
| Other physical details |
ill. ; |
| Dimensions |
24 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Title |
TOC |
| Formatted contents note |
An Overview Regulations and Requirements for Controlling Impurities Isolation and Characterization Analytical Methodology Synthesis-Related Impurities Pharmaceutical Formulation-Related Impurities Kinetic Studies Stability Studies Applications |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Addresses the development of methodologies to monitor impurities in pharmaceutical compounds and drug products. This book introduces the techniques for isolating and characterizing impurities; presents guidelines to evaluate stability using kinetic studies; and more. It is for pharmacists and pharmacologists, clinical microbiologists, and others. |
| 526 ## - STUDY PROGRAM INFORMATION NOTE |
|---|
| Program name |
Pharmacy |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Rokon Mahamud |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Analysis. |
| 9 (RLIN) |
8809 |
|
|---|
| Topical term or geographic name as entry element |
Contamination (Technology) |
| 9 (RLIN) |
8810 |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
WorldCat detail |
| Uniform Resource Identifier |
https://www.worldcat.org/title/impurities-evaluation-of-pharmaceuticals/oclc/38270589&referer=brief_results |
|
|---|
| Materials specified |
Ebook Fulltext |
| Uniform Resource Identifier |
http://lib.ewubd.edu/ebook/5509 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Text |